z-logo
open-access-imgOpen Access
Nucleotide Substrate Specificity of Anti-Hepatitis C Virus Nucleoside Analogs for Human Mitochondrial RNA Polymerase
Author(s) -
Maryam Ehteshami,
Longhu Zhou,
Sheida Amiralaei,
Jadd R. Shelton,
Jong Hyun Cho,
Hongwang Zhang,
Hao Li,
Xiao Lu,
Tuğba Öztürk,
Richard A. Stanton,
Franck Amblard,
Tamara R. McBrayer,
Steven J. Coats,
Raymond F. Schinazi
Publication year - 2017
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00492-17
Subject(s) - virology , nucleoside , polymerase , rna dependent rna polymerase , nucleotide , virus , rna polymerase , hepatitis c virus , biology , rna , chemistry , enzyme , biochemistry , gene
Nucleoside analog inhibitors (NAIs) are an important class of antiviral agents. Although highly effective, some NAIs with activity against hepatitis C virus (HCV) can cause toxicity, presumably due to off-target inhibition of host mitochondrial RNA polymerase (POLRMT). The in vitro nucleotide substrate specificity of POLRMT was studied in order to explore structure-activity relationships that can facilitate the identification of nontoxic NAIs. These findings have important implications for the development of all anti-RNA virus NAIs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom